Global Health Limited

NSE: MEDANTA · Healthcare

Overview

Global Health Limited Share Price & Analysis

₹1,265.8▲ +0.60%Updated 19 Jun 2026, 05:01 pm IST
LTP
₹1,265.8
+0.6%
Open
₹—
High
₹1,281
Low
₹1,255.1
Close
₹1,265.8
52W High
₹1,456
52W Low
₹955
Volume
162K
Lot Size
1
Sector
Healthcare
Market Cap
₹33K Cr
Face Value
₹2
Large CapNIFTY 500

Price Chart

Fundamentals

P/E
59.6
Sector P/E
50.5
P/B
8.61
EPS
₹19.13
ROE
15.2%
ROCE
17.1%
D/E Ratio
0.3
Div Yield
0.04%
Book Value
₹147
+

Strengths

  • ✓Strong return on equity (ROE 15.2%)
  • ✓Efficient capital deployment (ROCE 17.1%)
  • ✓Low debt relative to equity (D/E 0.3x)
−

Concerns

  • ✗High premium to book value (P/B 8.6x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,840
₹4.3L Cr34.85.291620.50.07
DIVISLAB
Divi's Laboratories Limited
₹6,750
₹1.8L Cr67.210.716.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹4,424
₹1.5L Cr70.617.8427.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,486
₹1.2L Cr62.512.8822.117.90.88
CIPLA
Cipla Limited
₹1,353
₹1.1L Cr29.53.1811.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,072
₹1.1L Cr20.53.9921.221.20.38
DRREDDY
Dr. Reddy's Laboratories Limited
₹1,267
₹1.1L Cr25.42.7911.813.60.16

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

MEDANTA · as of Mar 2026

Promoters33.03%
FII11.76%▼0.72
DII11.93%▲1.42
Public43.28%▼0.70
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters33.05%33.04%33.04%33.04%33.03%33.03%
FII11.36%12.10%12.94%12.21%12.48%11.76%
DII11.15%10.25%10.57%11.11%10.51%11.93%
Public44.45%44.60%43.44%43.64%43.98%43.28%

Corporate Events

To consider and approve the financial results for the quarter and year ended March 31, 2026 and recommendation of final dividend, if any subject to shareholders approval.

Dividend13 May 2026

Dividend - Re 0.50 Per Share

Dividend21 Aug 2025

Latest News

All news →

India's services growth hits six-month high on strong domestic demand

*India's services growth hits six-month high on strong domestic demand.* The S&P Global Services PMI rose to **61.0** in May, the highest since November, driven by robust domestic demand. New orders surged with a sharp increase in business confidence. Output and employment expanded at faster rates. 📊 *STOCKS:* | 🏢 *SECTOR:* Macro | #HIGHIMPACT #PMI

The Economic Times3 Jun
High Impact

Avio appoints Sandeep Pandya to lead global healthcare expansion

*Avio appoints Sandeep Pandya to lead global healthcare expansion.* The move signals a strategic push into international diagnostics markets. Pandya brings **20+ years** of global healthcare experience. This leadership hire aims to scale the company’s footprint in emerging regions. 📊 *STOCKS:* AVIO | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Leadership

NSE Filing3d ago
Medium Impact

Global Health to host analyst and investor meet

*Global Health to host analyst and investor meet* to discuss business updates and performance. The event is scheduled as part of ongoing investor outreach. No financial figures or major announcements were disclosed. Details are based on a corporate filing with the NSE. 📊 *STOCKS:* MEDANTA | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Earnings

NSE Filing2d ago
Low Impact

Global Health to host investor call; details announced

*Global Health to host investor call; details announced*. Company has scheduled an analyst and institutional investor meet to discuss recent performance and outlook. Specific financial figures or strategic updates were not disclosed in the filing. The event is aimed at enhancing transparency and investor engagement. 📊 *STOCKS:* MEDANTA | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorMeet

NSE Filing2d ago
Low Impact

Global Health to host analyst and investor meet

*Global Health to host analyst and investor meet* to discuss recent performance and strategic updates. The session aims to enhance transparency and investor engagement. No financial results or major announcements are confirmed. 📊 *STOCKS:* MEDANTA | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Earnings

NSE Filing2d ago
Low Impact

Global Health plans medical college setup

*Global Health plans medical college setup* — The company announced plans to establish a medical college, marking an expansion in its healthcare education footprint. This strategic move aims to strengthen vertical integration. No financial details or timelines were disclosed. 📊 *STOCKS:* MEDANTA | 🏢 *SECTOR:* Corporate | #LOWIMPACT #medical

NSE Filing12 Jun
Low Impact

India's services sector growth hits six-month high in May.

*India's services sector growth hits six-month high in May.* The final S&P Global Services PMI rose to **58.9** in May from **57.1** in April, marking the fastest expansion since November. Strong demand and job creation boosted activity, signaling robust momentum in the services sector. 📊 *STOCKS:* | 🏢 *SECTOR:* Macro | #MEDIUMIMPACT #PMI

Moomoo3 Jun
Medium Impact

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹1.1K Cr
▲2.0%
₹1.1K Cr
▲6.6%
₹1.0K Cr
▲10.7%
₹931 Cr
▼1.3%
₹943 Cr
▼1.5%
₹957 Cr
▲11.1%
₹861 Cr
▲6.4%
₹809 Cr
Op. Profit
₹217 Cr
▼6.1%
₹231 Cr
▼6.5%
₹247 Cr
▲9.8%
₹225 Cr
▼5.5%
₹238 Cr
▲4.4%
₹228 Cr
▲22.6%
₹186 Cr
▲3.9%
₹179 Cr
OPM
19.0%
▼9.5%
21.0%
▼12.5%
24.0%
▲0.0%
24.0%
▼4.0%
25.0%
▲4.2%
24.0%
▲9.1%
22.0%
▲0.0%
22.0%
Net Profit
₹95 Cr
▼39.9%
₹158 Cr
▼0.6%
₹159 Cr
▲57.4%
₹101 Cr
▼29.4%
₹143 Cr
▲9.2%
₹131 Cr
▲23.6%
₹106 Cr
▼16.5%
₹127 Cr
EPS (₹)
3.54
▼39.9%
5.89
▼0.5%
5.92
▲56.6%
3.78
▼28.9%
5.32
▲9.2%
4.87
▲23.0%
3.96
▼16.5%
4.74

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
Revenue
₹4.4K Cr
▲19.4%
₹3.7K Cr
▲12.7%
₹3.3K Cr
▲20.8%
₹2.7K Cr
▲25.1%
₹2.2K Cr
▲49.8%
₹1.4K Cr
▼3.5%
₹1.5K Cr
▲3.0%
₹1.5K Cr
▲8.4%
₹1.3K Cr
▼2.8%
₹1.4K Cr
Expenses
₹3.5K Cr
▲24.4%
₹2.8K Cr
▲13.8%
₹2.5K Cr
▲19.0%
₹2.1K Cr
▲21.3%
₹1.7K Cr
▲36.7%
₹1.3K Cr
▼4.5%
₹1.3K Cr
▲2.0%
₹1.3K Cr
▲5.3%
₹1.2K Cr
▲12.7%
₹1.1K Cr
Op. Profit
₹919 Cr
▲3.7%
₹886 Cr
▲9.5%
₹809 Cr
▲27.0%
₹637 Cr
▲39.1%
₹458 Cr
▲132.5%
₹197 Cr
▲2.6%
₹192 Cr
▲11.6%
₹172 Cr
▲37.6%
₹125 Cr
▼58.5%
₹301 Cr
OPM
21.0%
▼12.5%
24.0%
▼4.0%
25.0%
▲4.2%
24.0%
▲14.3%
21.0%
▲50.0%
14.0%
▲7.7%
13.0%
▲8.3%
12.0%
▲33.3%
9.0%
▼59.1%
22.0%
Other Income
₹98 Cr
▲237.9%
₹29 Cr
▼61.3%
₹75 Cr
▲53.1%
₹49 Cr
▲25.6%
₹39 Cr
▲25.8%
₹31 Cr
▼29.5%
₹44 Cr
▼12.0%
₹50 Cr
▲2.0%
₹49 Cr
▲8.9%
₹45 Cr
Interest
₹79 Cr
▲6.8%
₹74 Cr
▼11.9%
₹84 Cr
▼2.3%
₹86 Cr
▲0.0%
₹86 Cr
▲17.8%
₹73 Cr
▲28.1%
₹57 Cr
▲50.0%
₹38 Cr
▲35.7%
₹28 Cr
▲100.0%
₹14 Cr
Depreciation
₹223 Cr
▲14.9%
₹194 Cr
▲12.1%
₹173 Cr
▲15.3%
₹150 Cr
▲15.4%
₹130 Cr
▲5.7%
₹123 Cr
▲7.0%
₹115 Cr
▲12.7%
₹102 Cr
▲18.6%
₹86 Cr
▲22.9%
₹70 Cr
PBT
₹715 Cr
▲10.5%
₹647 Cr
▲3.2%
₹627 Cr
▲39.6%
₹449 Cr
▲59.8%
₹281 Cr
▲778.1%
₹32 Cr
▼50.0%
₹64 Cr
▼22.9%
₹83 Cr
▲38.3%
₹60 Cr
▼77.1%
₹262 Cr
Tax %
23.0%
▼11.5%
26.0%
▲8.3%
24.0%
▼11.1%
27.0%
▼10.0%
30.0%
▲172.7%
11.0%
▼74.4%
43.0%
▲13.2%
38.0%
▼15.6%
45.0%
▲28.6%
35.0%
Net Profit
₹554 Cr
▲15.2%
₹481 Cr
▲0.6%
₹478 Cr
▲46.6%
₹326 Cr
▲66.3%
₹196 Cr
▲575.9%
₹29 Cr
▼19.4%
₹36 Cr
▼29.4%
₹51 Cr
▲54.5%
₹33 Cr
▼80.6%
₹170 Cr
EPS (₹)
20.7
▲15.5%
17.92
▲0.6%
17.81
▲46.5%
12.16
▲56.9%
7.75
▲33.4%
5.81
▼21.1%
7.36
▼29.5%
10.44
▲54.0%
6.78
▼80.7%
35.1
Div Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
Liabilities
Equity Capital
₹54 Cr
▲0.0%
₹54 Cr
▲0.0%
₹54 Cr
▲0.0%
₹54 Cr
▲5.9%
₹51 Cr
▲2.0%
₹50 Cr
▲2.0%
₹49 Cr
▲0.0%
₹49 Cr
▲2.1%
₹48 Cr
▲0.0%
₹48 Cr
Reserves
₹3.7K Cr
▲9.6%
₹3.3K Cr
▲16.9%
₹2.9K Cr
▲20.1%
₹2.4K Cr
▲51.8%
₹1.6K Cr
▲17.4%
₹1.3K Cr
▲2.5%
₹1.3K Cr
▲4.3%
₹1.2K Cr
▲9.7%
₹1.1K Cr
▲16.4%
₹976 Cr
Borrowings
₹945 Cr
▲31.6%
₹718 Cr
▼10.5%
₹802 Cr
▼28.5%
₹1.1K Cr
▲1.2%
₹1.1K Cr
▲19.1%
₹931 Cr
▲0.2%
₹929 Cr
▲18.0%
₹787 Cr
▲72.6%
₹456 Cr
▲176.4%
₹165 Cr
Other Liabilities
₹757 Cr
▲14.4%
₹662 Cr
▲15.7%
₹572 Cr
▲4.6%
₹547 Cr
▲29.9%
₹421 Cr
▲10.8%
₹380 Cr
▼2.1%
₹388 Cr
▲11.8%
₹347 Cr
▲1.2%
₹343 Cr
▲16.3%
₹295 Cr
Total Liabilities
₹5.4K Cr
▲13.5%
₹4.8K Cr
▲11.4%
₹4.3K Cr
▲4.5%
₹4.1K Cr
▲30.2%
₹3.1K Cr
▲16.8%
₹2.7K Cr
▲1.1%
₹2.7K Cr
▲9.7%
₹2.4K Cr
▲22.5%
₹2.0K Cr
▲33.6%
₹1.5K Cr
Assets
Fixed Assets
₹3.2K Cr
▲27.2%
₹2.5K Cr
▲12.4%
₹2.2K Cr
▲9.1%
₹2.0K Cr
▲15.4%
₹1.8K Cr
▲9.9%
₹1.6K Cr
▼5.1%
₹1.7K Cr
▲42.6%
₹1.2K Cr
▲9.1%
₹1.1K Cr
▲19.7%
₹914 Cr
CWIP
₹318 Cr
▼40.3%
₹533 Cr
▲37.4%
₹388 Cr
▲18.7%
₹327 Cr
▼25.5%
₹439 Cr
▼5.4%
₹464 Cr
▲21.5%
₹382 Cr
▼42.6%
₹666 Cr
▲110.1%
₹317 Cr
▲2541.7%
₹12 Cr
Investments
₹3 Cr
▲0.0%
₹3 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
Other Assets
₹1.9K Cr
▲10.1%
₹1.7K Cr
▲3.6%
₹1.7K Cr
▼3.7%
₹1.7K Cr
▲84.9%
₹930 Cr
▲51.2%
₹615 Cr
▲5.9%
₹581 Cr
▲1.9%
₹570 Cr
▼0.5%
₹573 Cr
▲2.5%
₹559 Cr
Total Assets
₹5.4K Cr
▲13.5%
₹4.8K Cr
▲11.4%
₹4.3K Cr
▲4.5%
₹4.1K Cr
▲30.2%
₹3.1K Cr
▲16.8%
₹2.7K Cr
▲1.1%
₹2.7K Cr
▲9.7%
₹2.4K Cr
▲22.5%
₹2.0K Cr
▲33.6%
₹1.5K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
Operating CF
₹714 Cr
▲14.4%
₹624 Cr
▲2.0%
₹612 Cr
▼5.1%
₹645 Cr
▲107.4%
₹311 Cr
▲28.5%
₹242 Cr
▲38.3%
₹175 Cr
▲5.4%
₹166 Cr
▲163.5%
₹63 Cr
▼72.4%
₹228 Cr
Investing CF
₹-1.1K Cr
▼51.0%
₹-721 Cr
▼63.5%
₹-441 Cr
▼28.9%
₹-342 Cr
▲18.8%
₹-421 Cr
▼76.2%
₹-239 Cr
▼174.7%
₹-87 Cr
▲65.1%
₹-249 Cr
▼260.9%
₹-69 Cr
▲71.4%
₹-241 Cr
Financing CF
₹272 Cr
▲380.4%
₹-97 Cr
▲81.1%
₹-514 Cr
▼248.6%
₹346 Cr
▲116.3%
₹160 Cr
▲297.5%
₹-81 Cr
▼8000.0%
₹-1 Cr
▼101.0%
₹97 Cr
▲977.8%
₹9 Cr
▲228.6%
₹-7 Cr
Net Cash Flow
₹-103 Cr
▲46.9%
₹-194 Cr
▲43.4%
₹-343 Cr
▼152.9%
₹648 Cr
▲1196.0%
₹50 Cr
▲164.1%
₹-78 Cr
▼189.7%
₹87 Cr
▲521.4%
₹14 Cr
▲366.7%
₹3 Cr
▲115.0%
₹-20 Cr
Free Cash Flow
₹-263 Cr
▼339.1%
₹110 Cr
▼67.2%
₹335 Cr
▼18.1%
₹409 Cr
▲976.3%
₹38 Cr
▼62.0%
₹100 Cr
▲869.2%
₹-13 Cr
▲90.2%
₹-133 Cr
▼64.2%
₹-81 Cr
▼214.1%
₹71 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
Debtor Days
34d
▲17.2%
29d
▲20.8%
24d
▼7.7%
26d
▼13.3%
30d
▼11.8%
34d
▼5.6%
36d
▼12.2%
41d
▲0.0%
41d
▲105.0%
20d
Inventory Days
29d
▲3.6%
28d
▼12.5%
32d
▼8.6%
35d
▼2.8%
36d
▼14.3%
42d
▼2.3%
43d
▲65.4%
26d
▲0.0%
26d
▼7.1%
28d
Days Payable
89d
▲9.9%
81d
▼10.0%
90d
▼21.1%
114d
▲26.7%
90d
▼34.8%
138d
▼6.1%
147d
▲3.5%
142d
▲14.5%
124d
▲34.8%
92d
Cash Conv. Cycle
-26d
▼8.3%
-24d
▲29.4%
-34d
▲34.6%
-52d
▼116.7%
-24d
▲61.3%
-62d
▲7.5%
-67d
▲10.7%
-75d
▼33.9%
-56d
▼24.4%
-45d
Working Capital Days
-7d
▲66.7%
-21d
▲34.4%
-32d
▲13.5%
-37d
▼85.0%
-20d
▲58.3%
-48d
▼54.8%
-31d
▼72.2%
-18d
▲45.5%
-33d
▼43.5%
-23d
ROCE
17.0%
▼15.0%
20.0%
▲0.0%
20.0%
▲17.6%
17.0%
▲13.3%
15.0%
▲200.0%
5.0%
▼16.7%
6.0%
▲0.0%
6.0%
—
—

Source: Screener.in · Lower days = better efficiency

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is Global Health Limited share price today?▾
Global Health Limited (MEDANTA) is currently trading at ₹1,265.8 on NSE, up 0.60% as of the last market session. Prices update daily after market close on MarketNetra.
Is Global Health Limited available in F&O (Futures & Options)?▾
Yes, Global Health Limited (MEDANTA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Global Health Limited 52-week high and low?▾
Global Health Limited's 52-week high is ₹1,456 and the 52-week low is ₹955. The current price of ₹1,265.8 is 13.1% below the 52W high.
What is Global Health Limited P/E ratio?▾
Global Health Limited's current P/E ratio is 59.6. This indicates the market is paying ₹59.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Global Health Limited options?▾
Global Health Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade MEDANTA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.